ArticleCureus2024

Investigation of the Efficacy of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor in Patients With EGFR Exon 21 L858R Point Mutation-Positive Non-small Cell Lung Cancer.

Yutaka Takahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.